Solved

The Development of Chronic Myelogenous Leukemia Tumor-Resistance to Gleevec Appears

Question 51

Multiple Choice

The development of chronic myelogenous leukemia tumor-resistance to Gleevec appears to usually be caused by mutations in the ABL portion of the fusion gene.Therefore,what is thought to be the best drug regimen for treating CML?


A) a cocktail of several different inhibitors that target different parts of the Abl protein
B) a cocktail of several different inhibitors that target the same parts of the Abl protein
C) a cocktail of several different inhibitors that target common domains of different proteins
D) a cocktail of several different inhibitors that target the different parts of different proteins
E) an aperetif

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions